About Ataraxis
Ataraxis is a company founded in 2022. Ataraxis has raised $40.4 million across 2 funding rounds from investors including Floating Point, AIX Ventures and Giant Ventures. Ataraxis offers products and services including Ataraxis Breast and Kestrel. Ataraxis operates in a competitive market with competitors including Remepy, Omda, MICA, Significo and Kiro, among others.
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ataraxis Ai, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$40.4 M (USD)
in 2 rounds
-
Latest Funding Round
$20.4 M (USD), Series A
Mar 05, 2025
-
Investors
Floating Point
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ataraxis
Ataraxis offers a comprehensive portfolio of products and services, including Ataraxis Breast and Kestrel.
AI tool to predict breast cancer recurrence and treatment responses.
Model for analyzing cancer pathology slides and patient outcomes.
Funding Insights of Ataraxis
Ataraxis has successfully raised a total of $40.4M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $20.4 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ataraxis
Ataraxis has secured backing from 6 investors, including venture fund and angel investors. Prominent investors backing the company include Floating Point, AIX Ventures and Giant Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to AI-powered companies by AIX Ventures.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on tech companies
|
Locked | Locked | Locked | |
|
Giant Ventures is engaged in venture capital investments for technology startups.
|
Locked | Locked | Locked |
Investor details for Ataraxis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ataraxis
Investment portfolio details for Ataraxis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ataraxis
Detailed financials for Ataraxis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ataraxis Comparisons
Peer comparison for Ataraxis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ataraxis
Ataraxis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Remepy, Omda, MICA, Significo and Kiro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Healthcare software applications are developed and provided for medical use.
|
|
| Locked | Locked | Locked |
Regulatory and security compliant software solutions are provided by Omda.
|
|
| Locked | Locked | Locked |
AI-based decision support systems are provided for radiologists.
|
|
| Locked | Locked | Locked |
Software development services are provided by Significo in Austin.
|
|
| Locked | Locked | Locked |
AI development services for healthcare sectors are provided.
|
Detailed competitors of Ataraxis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ataraxis
Complete news archive for Ataraxis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ataraxis
Ataraxis was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Ataraxis is a funded company, having raised a total of $40.4M across 2 funding rounds to date.
Ataraxis was established in 2022 as a provider in the healthcare technology sector. An AI-driven platform for diagnostics is developed and maintained by the company, focusing on analysis and support for medical evaluations. Services are delivered through digital means, with the domain ataraxis.ai serving as the primary access point. No specific geographic location is indicated for operations, though activities center on AI integration for diagnostic processes. (68 words).
Ataraxis's top competitors include Digital Autopsy, MICA and Remepy.
Ataraxis offers Ataraxis Breast and Kestrel.
Ataraxis has 6 investors. Key investors include Floating Point, AIX Ventures, Giant Ventures, Obvious Ventures, and Peter Thiel.